AbbVie (NY: ABBV )
158.49
-8.80
(-5.26%)
Streaming Delayed Price
Updated: 1:12 PM EDT, Apr 26, 2024
Add to My Watchlist
Press Releases about AbbVie
Johnson & Johnson: Taking The Bull By The Horns?
February 21, 2023
Via MarketBeat
AbbVie Has a Mixed Outlook After Mixed Earnings
February 13, 2023
Via MarketBeat
AbbVie Stock: Dividend King ABBV Overview
January 19, 2023
Via MarketBeat
Can AbbVie Grow Revenue When Humira Biosimilars Hit The Market?
November 16, 2022
Via MarketBeat
Topics
Intellectual Property
Exposures
Intellectual Property
One in Five Americans Who Have Been Infected With the Virus Said to Have Long COVID
November 17, 2022
Exposures
COVID-19
Via PressReach
Topics
Economy
CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Appoints New Board Member
September 02, 2022
Topics
Intellectual Property
CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Appoints New Board Member
September 02, 2022
Via CannabisNewsWire
Topics
Intellectual Property
Two Appealing Biotech Stocks for Two Distinct investors
August 08, 2022
Via MarketBeat
Topics
Intellectual Property
MarketBeat: Week in Review 7/25 – 7/29
July 30, 2022
Via MarketBeat
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.